Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Bull4u2on Sep 20, 2017 1:25pm

74 Views

Post# 26720672

RE:RE:News

And who exactly is We? Can we expect this so called FDA application to be finalized this year, or will we we wait another year to finally get it approved?

eunice12 wrote: There is no such thing as an interim report on your application. But if you want one here it is.

"""""""""We are working diligently to apply to the FDA and are making progress every month.""""""""""

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario